Mirna Clerie
Physician Assistant · Washington, DCNPI 1942447974
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $50.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$532
- AstraZeneca$499
- Johnson & Johnson$483
- Novartis$281
- Puma Biotechnology, Inc.$152
- E.r. Squibb & Sons, L.L.C.$125
- plus $898 from 19 others
What the payments were for
- Food & beverage$2,87197%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $532 |
| AstraZeneca(2 entities) | 9 | $499 |
| Johnson & Johnson(2 entities) | 6 | $483 |
| Novartis | 12 | $281 |
| Puma Biotechnology, Inc. | 3 | $152 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Seagen Inc. | 1 | $119 |
| Ipsen Biopharmaceuticals, Inc | 1 | $93 |
| Gilead | 1 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| GSK | 1 | $76 |
| Coherus Oncology, Inc. | 1 | $75 |
| Sobi, Inc | 2 | $48 |
| Merck | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Astellas Pharma US Inc | 1 | $32 |
| Invivyd Inc | 1 | $29 |
| Mirati Therapeutics, Inc. | 1 | $26 |
| Agios Pharmaceuticals, Inc. | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Beigene USA, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,971 in reported general payments places this provider in the 90th percentile of 372 physician assistant providers in District of Columbia.
See all physician assistant providers in District of Columbia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 37 | $1,079 |
| Letrozole | 39 | $687 |
| Alendronate Sodium | 14 | $173 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Washington
- Shana PermanWashington$36K
- Keriann KupermanWashington$24K
- Harleen BathWashington$18K
- Dustin FronczakWashington$13K
- Irena CulicWashington$13K
- Catherine UgliettaWashington$9K
- Milajurine LindsayWashington$9K
- Joseph HudsonWashington$8K
- Sonia BahrooWashington$7K
- Ryan WierWashington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.